Binding mechanisms of 1,4-dihydropyridine derivatives to L-type calcium channel Cav1.2: a molecular modeling study.

L-type Ca(2+) channels (LTCCs), the heteromultimeric proteins, are associated with electrical signaling and provide the key link between electrical signals and non-electrical processes. 1,4-Dihydropyridine (DHP) derivatives are a major class of blockers for LTCCs, and have experienced widespread use in the treatment of cardiovascular diseases. However, the precise knowledge of the binding mechanism of these ligands to LTCCs at the atomic level has remained unknown because of the unavailability of the crystal structures of LTCCs. In this study, homology modeling, molecular docking, molecular dynamics (MD) simulations, free energy calculations and decomposition were employed to explore the structural requirement of the binding of DHP derivatives to human Cav1.2, a member of LTCCs. The binding conformations of the DHPs in the active site of Cav1.2 were predicted, and the rank of the binding free energies of Cav1.2/DHPs is generally consistent with the experimental data. The structural analysis shows that most studied ligands fit into a hydrophobic pocket formed by Phe1129, Ile1173, Phe1176, Met1177 and Met1509, and form aryl-aryl interaction with Phe1129 or Tyr1508. The consistency between the predictions and experimental data suggest that the developed model is reliable and can be used as a valuable platform for the structure-based design of new potent ligands of Cav1.2.

[1]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[2]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[3]  A. Cm,et al.  Two distinct populations of calcium channels in a clonal line of pituitary cells. , 1985 .

[4]  J. Arrowsmith,et al.  Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents. , 1986, Journal of medicinal chemistry.

[5]  M. Karplus,et al.  Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations , 1991, Proteins.

[6]  D. Eisenberg,et al.  Assessment of protein models with three-dimensional profiles , 1992, Nature.

[7]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[8]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[9]  W. Catterall,et al.  Molecular Determinants of High Affinity Phenylalkylamine Block of L-type Calcium Channels (*) , 1995, The Journal of Biological Chemistry.

[10]  W. Catterall,et al.  Calcium Binding in the Pore of L-type Calcium Channels Modulates High Affinity Dihydropyridine Binding (*) , 1995, The Journal of Biological Chemistry.

[11]  N. Klugbauer,et al.  The IVS6 segment of the L‐type calcium channel is critical for the action of dihydropyridines and phenylalkylamines. , 1996, The EMBO journal.

[12]  H. Glossmann,et al.  Transfer of 1,4-Dihydropyridine Sensitivity from L-Type to Class A (BI) Calcium Channels , 1996, Neuron.

[13]  W. Catterall,et al.  Molecular determinants of drug binding and action on L-type calcium channels. , 1997, Annual review of pharmacology and toxicology.

[14]  A. Schwartz,et al.  Motif III S5 of L-type Calcium Channels Is Involved in the Dihydropyridine Binding Site , 1997, The Journal of Biological Chemistry.

[15]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[16]  W. C. Still,et al.  Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) , 1999 .

[17]  Y. Okamura,et al.  Serine Residue in the IIIS5-S6 Linker of the L-type Ca2+ Channel α1C Subunit Is the Critical Determinant of the Action of Dihydropyridine Ca2+Channel Agonists* , 2000, The Journal of Biological Chemistry.

[18]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[19]  V. Ananthanarayanan,et al.  Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists. , 2001, Archives of biochemistry and biophysics.

[20]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[21]  D. Case,et al.  Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. , 2003, Journal of molecular biology.

[22]  H. Ichijo,et al.  Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists. , 2003, Molecular pharmacology.

[23]  H. Fozzard,et al.  Molecular modeling of interactions of dihydropyridines and phenylalkylamines with the inner pore of the L-type Ca2+ channel. , 2003, Molecular pharmacology.

[24]  D. Case,et al.  Exploring protein native states and large‐scale conformational changes with a modified generalized born model , 2004, Proteins.

[25]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[26]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[27]  W. Catterall,et al.  Allosteric Interactions Required for High-Affinity Binding of Dihydropyridine Antagonists to CaV1.1 Channels Are Modulated by Calcium in the Pore , 2006, Molecular Pharmacology.

[28]  Xiaojie Xu,et al.  Recent Advances in Free Energy Calculations with a Combination of Molecular Mechanics and Continuum Models , 2006 .

[29]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[30]  Ettore Novellino,et al.  Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculations. , 2007, Journal of medicinal chemistry.

[31]  Tingjun Hou,et al.  Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance. , 2007, Journal of medicinal chemistry.

[32]  Boris S Zhorov,et al.  Molecular Modeling of Benzothiazepine Binding in the L-type Calcium Channel* , 2008, Journal of Biological Chemistry.

[33]  D. Case,et al.  Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain. , 2008, Journal of molecular biology.

[34]  Boris S Zhorov,et al.  Structural Model for Dihydropyridine Binding to L-type Calcium Channels* , 2009, The Journal of Biological Chemistry.

[35]  A. Mehdipour,et al.  Dihydropyridines: evaluation of their current and future pharmacological applications. , 2009, Drug discovery today.

[36]  Oliver Beckstein,et al.  Lipidbook: A Public Repository for Force-Field Parameters Used in Membrane Simulations , 2010, The Journal of Membrane Biology.

[37]  Kenneth M Merz,et al.  Structural Survey of Zinc Containing Proteins and the Development of the Zinc AMBER Force Field (ZAFF). , 2010, Journal of chemical theory and computation.

[38]  G. Cruciani,et al.  1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs. , 2011, Current medicinal chemistry.

[39]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[40]  P. Lory,et al.  Hallmarks of the channelopathies associated with L-type calcium channels: a focus on the Timothy mutations in Ca(v)1.2 channels. , 2011, Biochimie.

[41]  Tingjun Hou,et al.  Structural Bioinformatics Prediction of Peptides Binding to the Pka Riiα Subunit Using a Hierarchical Strategy , 2022 .

[42]  Tingjun Hou,et al.  Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking , 2011, J. Comput. Chem..

[43]  Tingjun Hou,et al.  Concerted Movement in pH-Dependent Gating of FocA from Molecular Dynamics Simulations , 2012, J. Chem. Inf. Model..

[44]  Wei Wang,et al.  Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models. , 2012, Journal of proteome research.

[45]  Xiong Cao,et al.  An L-Type Calcium Channel Agonist, Bay K8644, Extends the Window of Intervention Against Ischemic Neuronal Injury , 2012, Molecular Neurobiology.

[46]  Tingjun Hou,et al.  Studies on the Interactions between β2 Adrenergic Receptor and Gs Protein by Molecular Dynamics Simulations , 2012, J. Chem. Inf. Model..

[47]  Xiaojie Jin,et al.  Exploring the Molecular Mechanism of Cross-Resistance to HIV-1 Integrase Strand Transfer Inhibitors by Molecular Dynamics Simulation and Residue Interaction Network Analysis , 2013, J. Chem. Inf. Model..

[48]  Dan Li,et al.  Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches. , 2013, Molecular bioSystems.

[49]  Youyong Li,et al.  Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models. , 2013, The journal of physical chemistry. B.

[50]  T. Stockner,et al.  What can naturally occurring mutations tell us about Cav1.x channel function? , 2013, Biochimica et biophysica acta.

[51]  W. Catterall,et al.  Structural basis for Ca2+ selectivity of a voltage-gated calcium channel , 2013, Nature.

[52]  Peng Yang,et al.  Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs , 2014, J. Chem. Inf. Model..

[53]  G. Zamponi,et al.  Neuronal Voltage-Gated Calcium Channels: Structure, Function, and Dysfunction , 2014, Neuron.

[54]  R. Gust,et al.  Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators , 2014, Nature Communications.

[55]  Tingjun Hou,et al.  Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. , 2014, Physical chemistry chemical physics : PCCP.

[56]  Huanxiang Liu,et al.  Computational Study on the Inhibitor Binding Mode and Allosteric Regulation Mechanism in Hepatitis C Virus NS3/4A Protein , 2014, PloS one.

[57]  Youyong Li,et al.  Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. , 2014, Physical chemistry chemical physics : PCCP.

[58]  Huanxiang Liu,et al.  Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598. , 2014, Antiviral research.

[59]  J. Hescheler,et al.  Voltage-gated calcium channels: Determinants of channel function and modulation by inorganic cations , 2015, Progress in Neurobiology.